Seeking Alpha

Transcept Pharmaceuticals (TSPT) has resumed trading, and is now up 17.6% in the wake of the...

Transcept Pharmaceuticals (TSPT) has resumed trading, and is now up 17.6% in the wake of the FDA's approval of its Intermezzo insomnia drug.
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Tools
Find the right ETFs for your portfolio:
Seeking Alpha's new ETF Hub
ETF Investment Guide:
Table of Contents | One Page Summary
Read about different ETF Asset Classes:
ETF Selector

Next headline on your portfolio:

|